Gemcitabine sensitivity factors, hENT1 and RRM1 as potential prognostic biomarker for advanced biliary tract cancer

Background and aims: Biliary tract caner (BTC) is one of rare malignant disease with poor prognosis. Gemcitabine has been widely used as chemotherapeutic agent for advanced BTC treatment. Several molecules involved in gemcitabine metabolism, including human equilibrative nucleoside transporter (hENT...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Clin Exp Med
Asıl Yazarlar: Deng, Ting, Pan, Hong, Han, Rubing, Huang, Dingzhi, Li, Hongli, Zhou, Likun, Wang, Xia, Bai, Ming, Li, Xiang, Liu, Rui, Ge, Shaohua, Ning, Tao, Zhang, Le, Ba, Yi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2014
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307450/
https://ncbi.nlm.nih.gov/pubmed/25664003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller